Best Pract Res Clin Haematol. 2008 Sep;21(3):421-36.

Vaccine therapy and chronic lymphocytic leukaemia.

Source

Institute of Cancer, Barts and The London School of Medicine, University of London, Charterhouse Square, London EC1M 6BQ, UK.

Abstract

B-cell chronic lymphocytic leukaemia (CLL) should be an ideal target for immune-mediated responses. CLL arises from B cells that can act as antigen-presenting cells (APCs), expresses unique tumour antigens, and has been shown to be a target of the allogeneic T cells which mediate a graft-versus-leukaemia effect. Despite these potential benefits, immune responses against CLL cells have been difficult to elicit. CLL induces immune defects in the host, the tumour cells are inefficient APCs, and therapies given to patients with CLL are themselves immunosuppressive. Successful vaccination approaches in this disease will require steps to overcome these difficulties, including identification of the targets of immune responses in this disease to enable monitoring of the immune response after vaccination, improved presentation of antigens, and steps to improve the immune defects that accompany this disease.

PMID:: 18790447; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Review Vaccine- and immune-based therapy in chronic lymphocytic leukemia. [Semin Oncol. 2006]
Review Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
Le Dieu R, Gribben J. Semin Oncol. 2006 Apr; 33(2):220-9.
CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. [Blood. 1999]
CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
Buhmann R, Nolte A, Westhaus D, Emmerich B, Hallek M. Blood. 1999 Mar 15; 93(6):1992-2002.
Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes. [Hum Gene Ther. 2001]
Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S, Rousseau RF, Yotnda P, Mei Z, Dotti G, Rill D, Hurwitz R, Marini F, Andreeff M, Brenner MK. Hum Gene Ther. 2001 Apr 10; 12(6):659-70.
A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia. [J Immunother. 2008]
A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.
Kronenberger K, Nössner E, Frankenberger B, Wahl U, Dreyling M, Hallek M, Mocikat R. J Immunother. 2008 Oct; 31(8):723-30.
Review Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. [Leuk Lymphoma. 2003]
Review Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S, Goddard RV, Kaminski ER, Prentice AG. Leuk Lymphoma. 2003 Mar; 44(3):383-9.

See reviews... See all...

Cited by 1 PubMed Central article

Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. [Blood. 2010]
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
Lapalombella R, Andritsos L, Liu Q, May SE, Browning R, Pham LV, Blum KA, Blum W, Ramanunni A, Raymond CA, et al. Blood. 2010 Apr 1; 115(13):2619-29. Epub 2009 Nov 24.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Vaccine therapy and chronic lymphocytic leukaemia.
Vaccine therapy and chronic lymphocytic leukaemia.
Best Pract Res Clin Haematol. 2008 Sep ;21(3):421-36.

PubMed
Importance of the propulsive phase in strength assessment.
Importance of the propulsive phase in strength assessment.
Int J Sports Med. 2010 Feb ;31(2):123-9. Epub 2009 Dec 17 .

PubMed
Tramtrack co-operates to prevent inappropriate neural development in Drosophila.
Tramtrack co-operates to prevent inappropriate neural development in Drosophila.
Mech Dev. 2002 Sep ;117(1-2):87-101.

PubMed
Regulation of gap junction coupling in bovine ciliary epithelium.
Regulation of gap junction coupling in bovine ciliary epithelium.
Am J Physiol Cell Physiol. 2010 Apr ;298(4):C798-806. Epub 2010 Jan 20 .

PubMed
Critical role of the platelet-derived growth factor receptor (PDGFR) beta transm...
Critical role of the platelet-derived growth factor receptor (PDGFR) beta transmembrane domain in the TEL-PDGFRbeta cytosolic oncoprotein.
J Biol Chem. 2010 Apr 16 ;285(16):12268-78. Epub 2010 Feb 17 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Vaccine therapy and chronic lymphocytic leukaemia.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information